Financials Amyris, Inc.

Equities

AMRS

US03236M2008

Specialty Chemicals

Delayed OTC Markets 10:59:36 2024-05-07 am EDT 5-day change 1st Jan Change
0.002 USD 0.00% Intraday chart for Amyris, Inc. -60.00% -20.00%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 161.4 254.4 326 1,477 1,668 556.1
Enterprise Value (EV) 1 269.9 419.4 614.8 1,729 1,629 1,473
P/E ratio -1.3 x -0.9 x -1.16 x -3.28 x -5.55 x -0.9 x
Yield - - - - - -
Capitalization / Revenue 1.13 x 4 x 2.14 x 8.53 x 4.88 x 2.06 x
EV / Revenue 1.88 x 6.59 x 4.03 x 9.99 x 4.77 x 5.46 x
EV / EBITDA -9.59 x -3.28 x -5.25 x -15.2 x -10.5 x -2.56 x
EV / FCF -7.15 x -5.75 x -7.17 x -11.8 x -22.8 x -3.82 x
FCF Yield -14% -17.4% -13.9% -8.46% -4.38% -26.1%
Price to Book -0.85 x -1.17 x -1.42 x -8.55 x 6.78 x -1.14 x
Nbr of stocks (in thousands) 43,034 76,163 105,503 239,211 308,239 363,492
Reference price 2 3.750 3.340 3.090 6.175 5.410 1.530
Announcement Date 4/17/18 10/1/19 3/13/20 3/5/21 3/9/22 3/16/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 143.4 63.6 152.6 173.1 341.8 269.8
EBITDA 1 -28.16 -127.8 -117.1 -114.1 -155.7 -575.8
EBIT 1 -39.52 -132.7 -121.7 -123.4 -165.4 -592.7
Operating Margin -27.55% -208.66% -79.76% -71.29% -48.39% -219.63%
Earnings before Tax (EBT) 1 -72.03 -230.2 -242.1 -326.6 -279.9 -546.1
Net income 1 -72.33 -230.2 -242.8 -331 -271 -528.5
Net margin -50.42% -361.98% -159.13% -191.2% -79.27% -195.86%
EPS 2 -2.895 -3.693 -2.667 -1.880 -0.9746 -1.694
Free Cash Flow 1 -37.72 -72.96 -85.69 -146.3 -71.31 -385.2
FCF margin -26.3% -114.71% -56.17% -84.49% -20.86% -142.75%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/17/18 10/1/19 3/13/20 3/5/21 3/9/22 3/16/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 109 165 289 252 - 917
Net Cash position 1 - - - - 38.4 -
Leverage (Debt/EBITDA) -3.855 x -1.291 x -2.466 x -2.21 x - -1.593 x
Free Cash Flow 1 -37.7 -73 -85.7 -146 -71.3 -385
ROE (net income / shareholders' equity) 37.7% 106% 103% 153% -532% 547%
ROA (Net income/ Total Assets) -17.6% -61.7% -52.6% -40.2% -17.6% -41.6%
Assets 1 412 372.9 461.1 823.5 1,543 1,269
Book Value Per Share 2 -4.400 -2.840 -2.170 -0.7200 0.8000 -1.340
Cash Flow per Share 2 1.250 0.5900 0 0.1200 1.570 0.1800
Capex 1 4.41 12.5 13.1 12.8 45.6 106
Capex / Sales 3.08% 19.61% 8.57% 7.38% 13.35% 39.26%
Announcement Date 4/17/18 10/1/19 3/13/20 3/5/21 3/9/22 3/16/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. AMRS Stock
  4. Financials Amyris, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW